Skip to main content

Table 1 Baseline characteristics of study participants (N = 167)

From: Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor

Characteristic

 < 65 years (N = 79)

 ≥ 65 years (N = 88)

Total (N = 167)

Sex, n (%)

 Male

26 (32.9)

47 (53.4)

73 (43.7)

Age, years, n (%)

 Mean (SD)

47.3 (13.7)

70.9 (6.0)

59.7 (15.7)

 Median (range)

53 (23–64)

69 (65–89)

65 (23–89)

Comorbid diseases, n (%)

 Hypertension

15 (19.0)

51 (58.0)

66 (39.5)

 CHD

6 (7.6)

15 (17.0)

21 (12.6)

 Diabetes

5 (6.3)

19 (21.6)

24 (14.4)

 Hyperlipidemia

10 (12.7)

40 (45.5)

50 (29.9)

 IV history

25 (31.6)

26 (29.5)

51 (30.5)

  1. Abbreviations: SD Standard deviation, CHD Coronary heart disease, IV history Influenza vaccination history in the previous year